{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:12:01Z","timestamp":1790291521169,"version":"4.1.0"},"reference-count":149,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Breast cancer (BC) is a predominant malignancy among women globally, with its etiology remaining largely elusive. Diagnosis primarily relies on invasive histopathological methods, which are often limited by sample representation and processing time. Consequently, non-invasive imaging techniques such as mammography, ultrasound, and Magnetic Resonance Imaging (MRI) are indispensable for BC screening, diagnosis, staging, and treatment monitoring. Recent advancements in imaging technologies and artificial intelligence-driven radiomics have enhanced precision medicine by enabling early detection, accurate molecular subtyping, and personalized therapeutic strategies. Despite reductions in mortality through traditional treatments, challenges like tumor heterogeneity and therapeutic resistance persist. Immunotherapies, particularly PD-1\/PD-L1 inhibitors, have emerged as promising alternatives. This review explores recent developments in BC imaging diagnostics and immunotherapeutic approaches, aiming to inform clinical practices and optimize therapeutic outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1560257","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T07:17:50Z","timestamp":1742195870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["New progress in imaging diagnosis and immunotherapy of breast cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Jie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"107992","DOI":"10.1016\/j.pharmthera.2021.107992","article-title":"Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression","volume":"232","author":"Sui","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/CPath.S31563","article-title":"Diversity of breast carcinoma: histological subtypes and clinical relevance","volume":"8","author":"Makki","year":"2015","journal-title":"Clin Med Insights Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.222893","article-title":"Introduction to radiomics","volume":"61","author":"Mayerhoefer","year":"2020","journal-title":"J Nucl Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S184710","article-title":"Immunotherapy for the treatment of breast cancer: emerging new data","volume":"11","author":"Mina","year":"2019","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.21037\/atm-22-1284","article-title":"Severe immune-related hepatitis and myocarditis caused by PD-1 inhibitors in the treatment of triple-negative breast cancer: a case report","volume":"10","author":"Yang","year":"2022","journal-title":"Ann Transl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.19.00127","article-title":"Ultrasound for breast cancer detection globally: A systematic review and meta-analysis","volume":"5","author":"Sood","year":"2019","journal-title":"J Glob Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10396-024-01444-w","article-title":"Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US","volume":"51","author":"Mori","year":"2024","journal-title":"J Med Ultrason (2001)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.665240","article-title":"Preoperative nomogram for predicting sentinel lymph node metastasis risk in breast cancer: A potential application on omitting sentinel lymph node biopsy","volume":"11","author":"Hu","year":"2021","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0080-3","article-title":"Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis","volume":"118","author":"Rebolj","year":"2018","journal-title":"Br J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.8372","article-title":"Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk","volume":"179","author":"Lee","year":"2019","journal-title":"JAMA Intern Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7150\/thno.18650","article-title":"Ultrasound elastography: review of techniques and clinical applications","volume":"7","author":"Sigrist","year":"2017","journal-title":"Theranostics"},{"key":"B13","first-page":"69","article-title":"Elastosonography in the diagnosis of the nodular breast lesions: preliminary report","volume":"110","author":"Giuseppetti","year":"2005","journal-title":"Radiol Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2015.03.009","article-title":"WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology","volume":"41","author":"Shiina","year":"2015","journal-title":"Ultrasound Med Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2021.07.009","article-title":"Utility of B-Mode, color doppler and elastography in the diagnosis of breast cancer: results of the CD-CONFIRM multicenter study of 1351 breast solid masses","volume":"47","author":"Watanabe","year":"2021","journal-title":"Ultrasound Med Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2021.11.005","article-title":"The potential of combined shear wave and strain elastography to reduce unnecessary biopsies in breast cancer diagnostics - An international, multicentre trial","volume":"161","author":"Golatta","year":"2022","journal-title":"Eur J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-2006-927226","article-title":"Benign and Malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging","volume":"28","author":"Ricci","year":"2007","journal-title":"Ultraschall Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jum.15886","article-title":"Association between contrast-enhanced ultrasound characteristics and molecular subtypes of breast cancer","volume":"41","author":"Wen","year":"2022","journal-title":"J Ultrasound Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.21037\/qims-21-416","article-title":"The value of contrast-enhanced ultrasound enhancement patterns for the diagnosis of sentinel lymph node status in breast cancer: systematic review and meta-analysis","volume":"12","author":"Niu","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.21037\/qims-23-1210","article-title":"The value of the improved percutaneous and intravenous contrast-enhanced ultrasound diagnostic classification in sentinel lymph nodes of breast cancer","volume":"14","author":"Huang","year":"2024","journal-title":"Quant Imaging Med Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.21767\/AMJ.2017.3034","article-title":"Initial experience with contrast-enhanced ultrasonography in follow-up assessment of small breast cancer treated by cryoablation","volume":"10","author":"Kinoshita","year":"2017","journal-title":"Australasian Medical Journal"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7863\/ultra.16.05060","article-title":"Accuracy of contrast-enhanced ultrasound compared with magnetic resonance imaging in assessing the tumor response after neoadjuvant chemotherapy for breast cancer","volume":"36","author":"Lee","year":"2017","journal-title":"J Ultrasound Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025908","article-title":"Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer","volume":"100","author":"Peng","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1722156","article-title":"Comparison of automated breast ultrasound and hand-held breast ultrasound in the screening of dense breasts","volume":"43","author":"Philadelpho","year":"2021","journal-title":"Rev Bras Ginecol Obstet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43055-019-0032-9","article-title":"Automated breast ultrasound (ABUS) as a screening tool: initial experience","volume":"50","author":"Mostafa","year":"2019","journal-title":"Egyptian Journal of Radiology and Nuclear Medicine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-020-01250-7","article-title":"The value of coronal view as a stand-alone assessment in women undergoing automated breast ultrasound","volume":"126","author":"Schiaffino","year":"2021","journal-title":"Radiol Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11090875","article-title":"Second-generation 3D automated breast ultrasonography (Prone ABUS) for dense breast cancer screening integrated to mammography: effectiveness, performance and detection rates","volume":"11","author":"Gatta","year":"2021","journal-title":"J Pers Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3934\/mbe.2021184","article-title":"Differential diagnosis of breast cancer assisted by S-Detect artificial intelligence system","volume":"18","author":"Xia","year":"2021","journal-title":"Math Biosci Eng"},{"key":"B29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jum.15684","article-title":"Diagnostic performance of an artificial intelligence system in breast ultrasound","volume":"41","author":"O\u2019Connell","year":"2022","journal-title":"J Ultrasound Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s43055-023-01183-x","article-title":"Value of S-Detect combined with multimodal ultrasound in differentiating Malignant from benign breast masses","volume":"55","author":"Li","year":"2024","journal-title":"Egyptian Journal of Radiology and Nuclear Medicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/j.tvir.2013.12.005","article-title":"Ultrasound-guided percutaneous breast biopsy","volume":"17","author":"Newell","year":"2014","journal-title":"Tech Vasc Interv Radiol"},{"key":"B32","article-title":"Clinical study of percutaneous ultrasound-guided or freehand core needle biopsy of primary breast cancer","volume":"43","author":"Ouyang","year":"2005","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215443","article-title":"B3 Lesions at Vacuum-Assisted Breast Biopsy under Ultrasound or Mammography Guidance: A Single-Center Experience on 3634 Consecutive Biopsies","volume":"13","author":"Girardi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/0284185114524197","article-title":"Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes","volume":"56","author":"Bae","year":"2015","journal-title":"Acta Radiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12880-020-00497-w","article-title":"Comparison of BSGI, MRI, mammography, and ultrasound for the diagnosis of breast lesions and their correlations with specific molecular subtypes in Chinese women","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Med Imaging"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.18383\/j.tom.2018.00046","article-title":"Early prediction of breast cancer therapy response using multiresolution fractal analysis of DCE-MRI parametric maps","volume":"5","author":"Machireddy","year":"2019","journal-title":"Tomography"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26700","article-title":"Proton MR spectroscopy in the breast: Technical innovations and clinical applications","volume":"50","author":"Fardanesh","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13121856","article-title":"Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T\u2013systematic review and meta-analysis","volume":"267","author":"Baltzer","year":"2013","journal-title":"Radiology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jmri.25560","article-title":"MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial","volume":"46","author":"Bolan","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18822","article-title":"Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers","volume":"8","author":"Choi","year":"2017","journal-title":"Oncotarget"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11102096","article-title":"Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and Malignant breast lesions","volume":"261","author":"Gruber","year":"2011","journal-title":"Radiology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019181136","article-title":"Performance of screening breast MRI across women with different elevated breast cancer risk indications","volume":"292","author":"Sippo","year":"2019","journal-title":"Radiology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/RMR.0000000000000137","article-title":"Amornsiripanitch N: DWI in the assessment of breast lesions","volume":"26","author":"Partridge","year":"2017","journal-title":"Top Magn Reson Imaging"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2016.11.029","article-title":"Role of pharmacokinetic parameters derived with high temporal resolution DCE MRI using simultaneous PET\/MRI system in breast cancer: A feasibility study","volume":"86","author":"Jena","year":"2017","journal-title":"Eur J Radiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12967-019-1911-6","article-title":"The volumetric-tumour histogram-based analysis of intravoxel incoherent motion and non-Gaussian diffusion MRI: association with prognostic factors in HER2-positive breast cancer","volume":"17","author":"You","year":"2019","journal-title":"J Transl Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25612","article-title":"Multiparametric diffusion-weighted imaging in breast lesions: Association with pathologic diagnosis and prognostic factors","volume":"46","author":"Suo","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2017.06.016","article-title":"Differentiation between luminal-A and luminal-B breast cancer using intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging","volume":"24","author":"Kawashima","year":"2017","journal-title":"Acad Radiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2016.10.005","article-title":"Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and Malignant breast lesions","volume":"36","author":"Ma","year":"2017","journal-title":"Magn Reson Imaging"},{"key":"B49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.mri.2019.07.011","article-title":"Diffusional kurtosis imaging for differentiation of additional suspicious lesions on preoperative breast MRI of patients with known breast cancer","volume":"62","author":"Park","year":"2019","journal-title":"Magn Reson Imaging"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s12609-016-0224-5","article-title":": Can Tomosynthesis replace 2D mammography as a future breast screening tool","volume":"8","author":"Durand","year":"2016","journal-title":"Current Breast Cancer Reports"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052911","article-title":"Digital tomosynthesis: a new future for breast imaging","volume":"68","author":"Alakhras","year":"2013","journal-title":"Clin Radiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052911","article-title":"Diagnostic performance of digital versus film mammography for breast-cancer screening","volume":"353","author":"Pisano","year":"2005","journal-title":"N Engl J Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.13.1081","article-title":"Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers","volume":"92","author":"Mandelson","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70134-7","article-title":"Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study","volume":"14","author":"Ciatto","year":"2013","journal-title":"Lancet Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/jncimono\/1997.22.119","article-title":"Radiation risk from screening mammography of women aged 40-49 years","volume":"1997","author":"Feig","year":"1997","journal-title":"J Natl Cancer Inst Monogr"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2213010334","article-title":"Dedicated breast CT: radiation dose and image quality evaluation","volume":"221","author":"Boone","year":"2001","journal-title":"Radiology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.16.17127","article-title":"Advances in digital breast tomosynthesis","volume":"208","author":"Hooley","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2463070410","article-title":"Dedicated breast CT: initial clinical experience","volume":"246","author":"Lindfors","year":"2008","journal-title":"Radiology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-006-9017-1","article-title":"Computed tomography for imaging the breast","volume":"11","author":"Boone","year":"2006","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1204460109","article-title":"High-resolution, low-dose phase contrast X-ray tomography for 3D diagnosis of human breast cancers","volume":"109","author":"Zhao","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2010.04.005","article-title":"The biology underlying molecular imaging in oncology: from genome to anatome and back again","volume":"65","author":"Gillies","year":"2010","journal-title":"Clin Radiol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.7150\/thno.30309","article-title":"The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.semcancer.2023.05.004","article-title":"Radiomics and artificial intelligence for precision medicine in lung cancer treatment","volume":"93","author":"Chen","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1038\/s41598-019-38502-0","article-title":"Preoperative prediction of axillary lymph node metastasis in breast cancer using radiomics features of DCE-MRI","volume":"9","author":"Cui","year":"2019","journal-title":"Sci Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1047572","article-title":"Intra- and peri-tumoral radiomics for predicting the sentinel lymph node metastasis in breast cancer based on preoperative mammography and MRI","volume":"12","author":"Cheng","year":"2022","journal-title":"Front Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-018-5891-3","article-title":"Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer","volume":"29","author":"Fan","year":"2019","journal-title":"Eur Radiol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-019-01383-w","article-title":"Radiomic signatures derived from diffusion-Weighted imaging for the assessment of breast cancer receptor status and molecular subtypes","volume":"22","author":"Leithner","year":"2020","journal-title":"Mol Imaging Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27910","article-title":"Evaluating tumor-infiltrating lymphocytes in breast cancer using preoperative MRI-based radiomics","volume":"55","author":"Bian","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773581","article-title":"Radiomics assessment of the tumor immune microenvironment to predict outcomes in breast cancer","volume":"12","author":"Han","year":"2021","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"110220","DOI":"10.1016\/j.ejrad.2022.110220","article-title":"A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer","volume":"149","author":"Jimenez","year":"2022","journal-title":"Eur J Radiol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2023.04.009","article-title":"Radiomics based on DCE-MRI for predicting response to neoadjuvant therapy in breast cancer","author":"Zeng","year":"2023","journal-title":"Acad Radiol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2020.10.020","article-title":"MRI radiomics for assessment of molecular subtype, pathological complete response, and residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy","author":"Choudhery","year":"2022","journal-title":"Acad Radiol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.28086","article-title":"Development and validation of a preoperative magnetic resonance imaging radiomics-Based signature to predict axillary lymph node metastasis and disease-Free survival in patients with early-Stage breast cancer","volume":"3","author":"Yu","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016160261","article-title":"Breast cancer heterogeneity: MR imaging texture analysis and survival outcomes","volume":"282","author":"Kim","year":"2017","journal-title":"Radiology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"16918","DOI":"10.1038\/s41598-023-44156-w","article-title":"Ultrasound-based radiomics combined with immune status to predict sentinel lymph node metastasis in primary breast cancer","volume":"13","author":"Zhao","year":"2023","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"103018","DOI":"10.1016\/j.ebiom.2020.103018","article-title":"Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer","volume":"60","author":"Guo","year":"2020","journal-title":"EBioMedicine"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1216446","article-title":"Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer","volume":"13","author":"Xu","year":"2023","journal-title":"Front Oncol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"20210188","DOI":"10.1259\/bjr.20210188","article-title":"Radiomics features on ultrasound imaging for the prediction of disease-free survival in triple negative breast cancer: a multi-institutional study","volume":"94","author":"Yu","year":"2021","journal-title":"Br J Radiol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10238-6","article-title":"Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer","volume":"34","author":"Cai","year":"2024","journal-title":"Eur Radiol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236182","article-title":"Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study results","volume":"15","author":"Quiaoit","year":"2020","journal-title":"PLoS One"},{"key":"B82","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","article-title":"Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"147","author":"Jiang","year":"2021","journal-title":"Eur J Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018180179","article-title":"Radiomic phenotypes of mammographic parenchymal complexity: toward augmenting breast density in breast cancer risk assessment","volume":"290","author":"Kontos","year":"2019","journal-title":"Radiology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41523-018-0078-2","article-title":"Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis","volume":"4","author":"Huang","year":"2018","journal-title":"NPJ Breast Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04313-8","article-title":"PET\/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy","volume":"46","author":"Antunovic","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3770-9","article-title":"(18)F]FDG PET\/CT features for the molecular characterization of primary breast tumors","volume":"44","author":"Antunovic","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41598-017-01524-7","article-title":"Metabolic radiomics for pretreatment (18)F-FDG PET\/CT to characterize locally advanced breast cancer: histopathologic characteristics, response to neoadjuvant chemotherapy, and prognosis","volume":"7","author":"Ha","year":"2017","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1247178","article-title":"Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors","volume":"14","author":"Xia","year":"2023","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1264325","article-title":"Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.965100","article-title":"Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1025330","article-title":"Ensemble deep learning enhanced with self-attention for predicting immunotherapeutic responses to cancers","volume":"13","author":"Jin","year":"2022","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12903-023-03138-0","article-title":"CD8 + T-cell marker genes reveal different immune subtypes of oral lichen planus by integrating single-cell RNA-seq and bulk RNA-sequencing","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Oral Health"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7554","article-title":"Role of immunotherapy in triple-negative breast cancer","volume":"18","author":"Keenan","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1201573","article-title":"A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts","volume":"14","author":"Ren","year":"2023","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1153423","article-title":"Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188760","article-title":"Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes","volume":"14","author":"Xiong","year":"2023","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1089410","article-title":"Exosomes: A potential tool for immunotherapy of ovarian cancer","volume":"13","author":"Gong","year":"2022","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"101032","DOI":"10.1016\/j.jhepr.2024.101032","article-title":"Oxytocin alleviates liver fibrosis via hepatic macrophages","volume":"6","author":"Zhai","year":"2024","journal-title":"JHEP Rep"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0404","article-title":"Decreased S1P and SPHK2 are involved in pancreatic acinar cell injury","volume":"13","author":"Xiao","year":"2019","journal-title":"biomark Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00859","article-title":"Mogroside II(E) inhibits digestive enzymes via suppression of interleukin 9\/interleukin 9 receptor signalling in acute pancreatitis","volume":"11","author":"Xiao","year":"2020","journal-title":"Front Pharmacol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00018-024-05114-5","article-title":"KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3\/Akt\/mTOR pathway","volume":"81","author":"Zhang","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e37060","DOI":"10.1016\/j.heliyon.2024.e37060","article-title":"Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment","volume":"10","author":"Deng","year":"2024","journal-title":"Heliyon"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"B105","doi-asserted-by":"publisher","first-page":"155458","DOI":"10.1016\/j.prp.2024.155458","article-title":"M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1","volume":"260","author":"Zhang","year":"2024","journal-title":"Pathol Res Pract"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2023.58","article-title":"Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies","volume":"6","author":"Wong","year":"2023","journal-title":"Cancer Drug Resist"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031235","article-title":"Targeting the PD-1\/PD-L1 signaling pathway for cancer therapy: focus on biomarkers","volume":"26","author":"Strati","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12100966","article-title":"Targeting both autophagy and immunotherapy in breast cancer treatment","volume":"12","author":"Giannopoulos","year":"2022","journal-title":"Metabolites"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4537-5","article-title":"Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study","volume":"167","author":"Dirix","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in patients with advanced triple-Negative breast cancer: phase Ib KEYNOTE-012 study","volume":"34","author":"Nanda","year":"2016","journal-title":"J Clin Oncol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/annonc\/mdy517","article-title":"Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann Oncol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1470-2045(20)30754-3","article-title":"Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial","volume":"22","author":"Winer","year":"2021","journal-title":"Lancet Oncol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamaoncol.2018.4224","article-title":"Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-Negative breast cancer: A phase 1 study","volume":"5","author":"Emens","year":"2019","journal-title":"JAMA Oncol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00005-021-00618-5","article-title":"CTLA-4 expression and its clinical significance in breast cancer","volume":"69","author":"Kern","year":"2021","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discovery"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B117","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S373780","article-title":"Targeting indoleamine dioxygenase and tryptophan dioxygenase in cancer immunotherapy: clinical progress and challenges","volume":"16","author":"Peng","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"B119","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3390\/pharmaceutics13122003","article-title":"Immunotherapy for triple-negative breast cancer","volume":"13","author":"Cao","year":"2021","journal-title":"Pharmaceutics"},{"key":"B121","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10549-004-3289-1","article-title":"Immunologic response to cryoablation of breast cancer","volume":"90","author":"Sabel","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0190","article-title":"A pilot study of preoperative single-dose ipilimumab and\/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling","volume":"22","author":"McArthur","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1507283","article-title":"CD8(+) T cell exhaustion in the tumor microenvironment of breast cancer","volume":"15","author":"Xie","year":"2024","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0013","article-title":"Deep sequencing of T-cell receptor DNA as a biomarker of clonally expanded TILs in breast cancer after immunotherapy","volume":"4","author":"Page","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28325","article-title":"Immune checkpoints: A therapeutic target in triple negative breast cancer","volume":"3","author":"Chawla","year":"2014","journal-title":"Oncoimmunology"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v4i11","article-title":"Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine","volume":"4","author":"Wrangle","year":"2013","journal-title":"Oncotarget"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1219008","article-title":"The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat","volume":"5","author":"Tomita","year":"2016","journal-title":"Oncoimmunology"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1325615","article-title":"Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications","volume":"14","author":"Yin","year":"2023","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12032-021-01556-0","article-title":"The effects of chemotherapeutic drugs on PD-L1 gene expression in breast cancer cell lines","volume":"38","author":"Majidi","year":"2021","journal-title":"Med Oncol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5152","article-title":"Atezolizumab plus nab-Paclitaxel in the treatment of metastatic triple-Negative breast cancer with 2-Year survival follow-up: A phase 1b clinical trial","volume":"5","author":"Adams","year":"2019","journal-title":"JAMA Oncol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.6650","article-title":"Effect of pembrolizumab plus neoadjuvant chemotherapy on pathologic complete response in women with early-Stage breast cancer: an analysis of the ongoing phase 2 adaptively randomized I-SPY2 trial","volume":"6","author":"Nanda","year":"2020","journal-title":"JAMA Oncol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J Clin Invest"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.7046","article-title":"Immune checkpoint inhibitor therapy in breast cancer","volume":"16","author":"Santa-Maria","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06408-z","article-title":"Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer","volume":"191","author":"Ho","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.610303","article-title":"The crosstalk between tumor cells and the immune microenvironment in breast cancer: implications for immunotherapy","volume":"11","author":"Salemme","year":"2021","journal-title":"Front Oncol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"PARP inhibitor efficacy depends on CD8(+) T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discovery"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-3215","article-title":"PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression","volume":"23","author":"Jiao","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1029","article-title":"Open-label clinical trial of niraparib combined with pembrolizumab for treatment of advanced or metastatic triple-Negative breast cancer","volume":"5","author":"Vinayak","year":"2019","journal-title":"JAMA Oncol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02736-z","article-title":"Pembrolizumab and atezolizumab in triple-negative breast cancer","volume":"70","author":"Kwapisz","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1125","article-title":"RAS\/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1\/PD-L1 immune checkpoint inhibitors","volume":"22","author":"Loi","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1135","article-title":"EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo","volume":"9","author":"Xia","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.573823","article-title":"Intercellular adhesion molecule-1 as target for CAR-T-Cell therapy of triple-Negative breast cancer","volume":"11","author":"Wei","year":"2020","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0189","article-title":"Safety and efficacy of intratumoral injections of chimeric antigen receptor (CAR) T cells in metastatic breast cancer","volume":"5","author":"Tchou","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/s41598-020-59736-3","article-title":"Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer","volume":"10","author":"Hu","year":"2020","journal-title":"Sci Rep"},{"key":"B146","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41421-018-0066-6","article-title":"A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma\/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release","volume":"4","author":"Xu","year":"2018","journal-title":"Cell Discovery"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168594","article-title":"Liquid biopsy in the clinical management of cancers","volume":"25","author":"Ho","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B148","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/1872210517666230613154847","article-title":"Emerging nanotechnology-based therapeutics: A new insight into promising drug delivery system for lung cancer therapy","volume":"18","author":"Verma","year":"2024","journal-title":"Recent Pat Nanotechnol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137208","article-title":"Breast cancer treatment strategies targeting the tumor microenvironment: how to convert \u201cCold\u201d Tumors to \u201cHot\u201d Tumors","volume":"25","author":"Yang","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560257\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T07:17:55Z","timestamp":1742195875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560257\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":149,"alternative-id":["10.3389\/fimmu.2025.1560257"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1560257","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"article-number":"1560257"}}